Observational studyJournal of neurology2026

First multicenter real-world analysis of switching to next-generation enzyme replacement therapies in late-onset Pompe disease.

Daniel H Mendelsohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.